Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SureNano Science is a Canadian life sciences company focused on the commercialization of a proprietary nanotechnology-based delivery system. The company's core product is the SureNano™ surfactant, a specialized nanoemulsion formulation designed to encapsulate oil-based active ingredients, such as cannabinoids and fat-soluble vitamins. This technology significantly enhances the bioavailability and solubility of these compounds, allowing them to be integrated into water-based products with improved stability and faster onset times. SureNano operates primarily through a licensing and distribution model, providing its formulation to manufacturers in the cannabis, functional food, and pharmaceutical sectors. The company is publicly traded on the Canadian Securities Exchange under the symbol SURE.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SureNano Science.